Phase II Trial of Gemcitabine, Cisplatin, Plus Ipilimumab as First-line Treatment for Patients With Metastatic Urothelial Carcinoma: Hoosier Cancer Research Network GU10-148
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Ipilimumab (Primary) ; Cisplatin; Gemcitabine
- Indications Bladder cancer; Renal cancer; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- 12 Jul 2018 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 01 May 2018 Results published in the European Urology 2018
- 06 Sep 2017 Planned End Date changed from 1 Nov 2017 to 1 Mar 2018.